Previous close | 0.0310 |
Open | 0.0310 |
Bid | 0.0310 x 166154000 |
Ask | 0.0320 x 165000000 |
Day's range | 0.0300 - 0.0320 |
52-week range | 0.0180 - 0.0340 |
Volume | |
Avg. volume | 4,052,419 |
Market cap | 65.824M |
Beta (5Y monthly) | -0.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0040 |
Earnings date | 30 Jan 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MELBOURNE, Australia, November 18, 2022--Patrys Limited (ASX: PAB, "Patrys" or the "Company"), a therapeutic antibody development company, has announced the appointment of Dr. Charmaine Gittleson as the Chairman of the Board of Directors – a highly respected and experienced global biotechnology leader.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...